Clinical Trial Update: PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rapid fentanyl for breakthrough pain at swallowing in head and neck cancer patients undergoing radiotherapy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• FENTANYL (FENTANYL)

Snippet

Sponsor: L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. | Conditions: Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain | Phase 3 | Status: WITHDRAWN